Journal
BIOMETALS
Volume 23, Issue 6, Pages 1085-1095Publisher
SPRINGER
DOI: 10.1007/s10534-010-9354-9
Keywords
Alzheimer's disease; Amyloid beta; Metal; Zinc transporters
Categories
Funding
- Ministry for Health and Welfare, Republic of Korea [A080201]
- Asan Institute for Life Sciences [2008-396]
- Korea Research Foundation [NRL2009-0066335, KPSEP2009-0081487]
- National Health and Medical Research Council of Australia
- Australian Research Council
- Alzheimer's Association
Ask authors/readers for more resources
Both apolipoprotein E (apoE) and zinc are involved in amyloid beta (A beta) aggregation and deposition, in the hallmark neuropathology of Alzheimer's disease (AD). Recent studies have suggested that interaction of apoE with metal ions may accelerate amyloidogenesis in the brain. Here we examined the impact of apoE deficiency on the histochemically reactive zinc pool in the brains of apoE knockout mice. While there was no change in total contents of metals (zinc, copper, and iron), the level of histochemically reactive zinc (principally synaptic zinc) was significantly reduced in the apoE-deficient brain compared to wild-type. This reduction was accompanied by reduced expressions of the presynaptic zinc transporter, ZnT3, as well as of the delta-subunit of the adaptor protein complex-3 (AP3 delta), which is responsible for post-translational stability and activity of ZnT3. In addition, the level of histochemically reactive zinc was also decreased in the cerebrovascular micro-vessels of apoE-deficient mice, the site of cerebral amyloid angiopathy in AD. These results suggest that apoE may affect the cerebral free zinc pool that contributes to AD pathology.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available